ライフサイエンスコーパス: -attracting

1 ls (DCs) and induced production of the T(H)2-attracting chemokines TARC (thymus and activation-regula

2 s encode a pollen tube growth-promoting and -attracting protein needed for optimal in vivo pollen tub

3 An example is the cat-attracting and insect-repelling volatile iridoid nepetal

4 ently stimulates the expression of Th-1 cell-attracting chemokines and chemokine receptors on the ocu

5 lecules and produce the T helper type 2 cell-attracting chemokine CCL17.

6 B cell-attracting chemokine 1 (BCA-1) responses correlate with

7 CNSL to investigate the expression of B cell-attracting chemokine 1 (BCA-1, CXCL13), a lymphoid chemo

8 uctures (B-cell activating factor and B cell-attracting chemokine 1).

9 The B cell-attracting chemokine CXCL13 is an important mediator in

10 expected expression of the follicular B cell-attracting chemokine CXCL13/BCA-1, suggesting a novel fo

11 -derived factor-1/CXCL12), and CXCR5 (B cell-attracting chemokine-1/CXCL13); but not to ligands for o

12 ed associations with NHL for elevated B-cell-attracting chemokine 1 (BCA-1; fourth quartile vs first:

13 d with increased plasma levels of the B-cell-attracting chemokine CXCL13.

14 lasmacytoid dendritic cells and CCR5(+ )cell-attracting chemokines produced by these cells, in combin

15 f the invariant natural killer T (iNKT) cell-attracting chemokine MCP-1 and of the antigen-presenting

16 rculating concentrations of the myeloid cell-attracting cytokines CXCL1 and CXCL5, enhanced local inf

17 We discovered a myeloid cell-attracting hub at the tumor-luminal interface associated

18 At least two cutaneous T cell-attracting chemokine (CTACK), three SLC, and four ELC ge

19 rization of a CC chemokine, cutaneous T cell-attracting chemokine (CTACK).

20 the keratinocyte-expressed cutaneous T cell-attracting chemokine (CTACK; CCL27), and MEC supports ch

21 Cutaneous T cell-attracting chemokine (CTACK; CCL27), expressed by skin k

22 New work showing that the T cell-attracting chemokine CCL2 can be posttranslationally mod

23 D80, CD83, CD86, IL-1, IL-12, and the T cell-attracting chemokine CCL27/CTACK) and consequently an en

24 mmunobiological properties, e.g., the T cell-attracting chemokine CCL27/CTACK, calcium-dependent prot

25 e) and neurotropic TG delivery of the T cell-attracting chemokine CXCL10 (pull), boosted the number a

26 he T cell-dependent production of the T cell-attracting chemokine macrophage inflammatory protein-1 a

27 sociated with the levels of cytotoxic T cell-attracting chemokines (C-C motif chemokine ligand 5 (CCL

28 ty hubs' defined by expression of the T cell-attracting chemokines CXCL10/CXCL11 and abundant T cells

29 loid cells; it induces the release of T cell-attracting chemokines from monocytes and, in particular,

30 ines were not increased and levels of T cell-attracting chemokines were decreased.

31 alignant and myeloid cells expressing T cell-attracting chemokines.

32 le to the epigenetic silencing of key T cell-attracting inflammatory chemokine genes in decidual stro

33 Importantly, TriMix mRNA induced a T-cell-attracting and stimulatory environment, including recrui

34 ction for chemoattractants: cutaneous T-cell-attracting chemokine (CTACK), thymus and activation-regu

35 emotactic responsiveness to cutaneous T-cell-attracting chemokine (CTACK)/CCL27 (a CCR10 ligand) para

36 oligomerization behavior of cutaneous T-cell-attracting chemokine (CTACK, also known as CCL27) by NMR

37 DC markers and enhanced expression of T-cell-attracting chemokine macrophage inflammatory protein 1-a

38 rived factor-1alpha, IP-10, cutaneous T-cell-attracting chemokine, monokine induced by IFN-gamma, tum

39 lated with intratumoral expression of T-cell-attracting chemokines and with T-cell infiltration.

40 ary, we have shown that monocyte- and T-cell-attracting chemokines are associated with monocyte and T

41 e effect of CXCL9, CXCL10, and CXCL11 T-cell-attracting chemokines on the frequency and function of D

42 uently causes increased expression of T-cell-attracting chemokines such as CXCL9, CXCL10, and CCL5.

43 8 expressing CXCL9, CXCL10, or CXCL11 T-cell-attracting chemokines to recruit T cells into the infect

44 Th2 cell-attracting CCL7 but not of Th1 cell-attracting chemokines.

45 ction site, i.e., the expression of Th2 cell-attracting CCL7 but not of Th1 cell-attracting chemokine

46 cal for eliciting production of the TH2 cell-attracting chemokine CCL17 by IRF4(+)CD11b(+)CD103(-) de

47 to the pathogenesis of HIV in vivo by chemo-attracting activated CD4+ cells to sites of viral replic

48 broblast function through secretion of chemo-attracting agents, as well as through growth factors and

49 erleukin-12, interferon-gamma, and chemokine-attracting T cells, and they induced antigen-specific T-

50 utocrine manner to trigger the release of DC-attracting chemokines, GM-CSF, and IL-33.

51 lity of enhancing tumor production of T(eff)-attracting chemokines as a cancer therapeutic strategy u

52 o hyperactivate NF-kappaB and produce T(eff)-attracting chemokines in response to treatment, resultin

53 ation of T(eff) express low levels of T(eff)-attracting chemokines such as CXCL10/IP10 and CCL5/RANTE

54 the QSAR for the interactions of 27 electron-attracting phenols in L1210 cells, log 1/ID50 = 0.56 log

55 o0F, demonstrated the importance of electron-attracting substituents in the salicyloyl ring and hydro

56 llows, which suggests that strongly electron-attracting and electron-rich radicals, together with bot

57 This response resulted in fewer eosinophil-attracting chemokines and reduced eosinophil recruitment

58 s males, but not females, produce the female-attracting dhas#18.

59 produce high levels of the immature DC (iDC)-attracting chemokines CCL3 and CCL4 upon exposure to tum

60 fresh fruits, such as tomato, and an insect-attracting scent in roses and many other flowers.

61 a (to create an artificial gradient of an LC-attracting chemokine) and topical application of hapten

62 erferon-gamma, interleukin-2, and lymphocyte-attracting chemokines within the tumor.

63 Of the two lymphocyte-attracting chemokines assessed, monocyte-chemotactic pro

64 TNF, and IFN-gamma), eosinophil and Mo/Mac -attracting chemokines (MCP-2, MCP-3, MCP-4 and CCL11).

65 L-6, TNF, and IFN-y), eosinophil and Mo/Mac -attracting chemokines (MCP-2, MCP-3, MCP-4 and CCL11).

66 increased expression of a single macrophage-attracting chemokine in the context of an inflammatory m

67 elay to reduced production of the macrophage-attracting chemokine MCP-1 in the gammadelta-T-cell-knoc

68 ted with T cell production of the macrophage-attracting chemokines CCL3 and CCL4.

69 ent production and release of the macrophage-attracting factors Csf2, Ccl3, and Il6.

70 tures, younger hermaphrodites secrete a male-attracting pheromone.

71 ides allowed full reconstitution of the male-attracting activity of wild-type pheromone extract.

72 vus females, but not males, produce the male-attracting ascr#1, whereas males, but not females, produ

73 lation and repressed gene expression of MDSC-attracting chemokines.

74 RT increased expression of PMN-MDSC-attracting chemokines, including CXCL1, CXLC3, and CSF3,

75 ASA treatment also reduced the MDSC-attracting chemokine CCL2 (C-C motif ligand 2) in the TM

76 dle ear infection, and upregulate a monocyte-attracting chemokine through TLR2-dependent NF-kappaB ac

77 XCL10, CXCL11, IFNgamma, IL-10, and monocyte-attracting CCL2, CCL7 and CCL8, was particularly evident

78 ytes also expressed the T-cell- and monocyte-attracting chemokine, CCL2, and the T-cell-supporting cy

79 owed diminished mRNA expression for monocyte-attracting chemokines, and significantly less CXCL9 and

80 tion of Bmal1 induces expression of monocyte-attracting chemokines and disrupts rhythmic cycling of L

81 Nod2 is responsible for regulating monocyte-attracting chemokines to the inflamed gut.

82 The monocyte-attracting chemokines CXCL9, 10, and 11 were preferentia

83 not impacted by human presence, but mosquito-attracting flowering plants competed with transgenic M.

84 ed a robust interleukin 8 (IL-8), neutrophil-attracting response to C. burnetii and ultimately shifte

85 ammatory activities, and Cxcl1, a neutrophil-attracting chemokine, as potential weak and strong direc

86 of proinflammatory cytokines and neutrophil-attracting chemokines, and enhanced pulmonary leukocyte

87 9, and T helper type 17-cell- and neutrophil-attracting chemokines.

88 Depleting neutrophils or blocking neutrophil-attracting chemokines restored normal histology in lymph

89 s through skeletal-muscle-derived neutrophil-attracting chemokines.

90 ed chemokine, one of the dominant neutrophil-attracting chemokines in mice, further revealed an indir

91 lergen-induced release of further neutrophil-attracting chemokines, migration of DCs to the draining

92 It also increases neutrophil-attracting chemokines resulting in recruitment and activ

93 At the gene expression level, neutrophil-attracting cytokines (IL19, CXCL8, CXCL5) were upregulat

94 ed with increases in the level of neutrophil-attracting chemokines KC and MIP-2, known to play a role

95 s required for their secretion of neutrophil-attracting chemokines.

96 L-17A to induce the expression of neutrophil-attracting chemokines.

97 tivity enhances the production of neutrophil-attracting factors and protects hyaluronic acid (HA) fro

98 increased lung production of the neutrophil-attracting chemokines CXCL-1 and CXCL-2.

99 70-modulated T cells, whereas the neutrophil-attracting chemokines CXCL1 and CXCL2 were up-regulated

100 mmatory cytokines, as well as the neutrophil-attracting chemokines Cxcl1 and Cxcl2, were increased.

101 IL-17F induced expression of the neutrophil-attracting chemokines CXCL1 and CXCL5 in kidney cells.

102 terleukin-1 (IL-1), IL-6, and the neutrophil-attracting chemokines KC, LIX, and MIP-2 was rapidly ind

103 which drive the expression of the neutrophil-attracting chemokines, are important for the clearance o

104 d that CD11b(+) DCs expressed the neutrophil-attracting cytokine CXCL2, whereas CD103(+) DCs expresse

105 atinocyte chemoattractant and the neutrophil-attracting cytokine IL-6 in corneas without HSK.

106 ocused on MIP-2 and KC/CXCL1, two neutrophil-attracting CXC chemokines.

107 rus (WNV), we found that expression of 2 PMN-attracting chemokines, Cxcl1 and Cxcl2, was rapidly and

108 brane deformation that could act as a proton-attracting funnel.

109 not the spherical globules expected of self-attracting long flexible polymers.

110 ich the DNA is either self-repelling or self-attracting.

111 ith published data, we demonstrate that self-attracting nucleolar organizing regions and repulsive co

112 oocytes that synthesize prostaglandin sperm-attracting cues.

113 d chemokine (MDC)/CCL22, I-309/CCL1) and Th1-attracting (IFN-gamma-inducible protein 10 (IP-10)/CXCL1

114 (TARC/CCL17, MDC/CCL22, I-309/CCL1), and Th1-attracting (IP-10/CXCL10, I-TAC/CXCL11) chemokines in th

115 of Ip10 and Cxcl9 transcripts, encoding Th1-attracting chemokines, were significantly reduced in the

116 sion of TSLP and Th2-attracting, but not Th1-attracting, chemokines as compared with controls, with s

117 of the PGE(2)-exposed DC to secrete the Th1-attracting chemokines: CXCL9, CXCL10, CXCL11, and CCL5.

118 High levels of the Th1-attracting, HIV-1-inhibitory chemokines, CCL3/MIP-1alpha

119 expression of TSLP and the same Th1- and Th2-attracting chemokines.

120 bronchial mucosal expression of TSLP and Th2-attracting, but not Th1-attracting, chemokines as compar

121 ression and cellular provenance of TSLP, Th2-attracting (TARC/CCL17, MDC/CCL22, I-309/CCL1), and Th1-

122 ression and cellular provenance of TSLP, Th2-attracting (thymus and activation-regulated chemokine (T

123 Both self-antigen-displaying and thymocyte-attracting mTEC subsets are essential for self-tolerance

124 that the sequential conversion of thymocyte-attracting subset into self-antigen-displaying subset se

125 f type I and type II IFNs, showing high Treg-attracting activity.

126 inflammation and cancer, induces stable Treg-attracting properties in maturing DC, mediated by CCL22.

127 cells (Treg) and the expression of the Treg-attracting chemokine Ccl17 by MHCII(high) tumor-associat

128 ndings argue that type I IFN blocks the Treg-attracting chemokine CCL22 and thus helps limit the recr

129 cells in BAL and greater levels of the Treg-attracting chemokine CCL22.

130 gamete fusion fails, one of two pollen tube-attracting synergid cells persists, enabling the ovule t